ATE444758T1 - Zelltherapie für chronischen schlaganfall - Google Patents

Zelltherapie für chronischen schlaganfall

Info

Publication number
ATE444758T1
ATE444758T1 AT00918005T AT00918005T ATE444758T1 AT E444758 T1 ATE444758 T1 AT E444758T1 AT 00918005 T AT00918005 T AT 00918005T AT 00918005 T AT00918005 T AT 00918005T AT E444758 T1 ATE444758 T1 AT E444758T1
Authority
AT
Austria
Prior art keywords
cells
stroke
disclosed
neuronal cells
composition
Prior art date
Application number
AT00918005T
Other languages
English (en)
Inventor
Paul Sanberg
Douglas Kondziolka
Michael Mcgrogan
Gary Snable
Original Assignee
Layton Bioscience Inc
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Layton Bioscience Inc, Univ South Florida filed Critical Layton Bioscience Inc
Application granted granted Critical
Publication of ATE444758T1 publication Critical patent/ATE444758T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00918005T 1999-04-27 2000-03-16 Zelltherapie für chronischen schlaganfall ATE444758T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13123099P 1999-04-27 1999-04-27
US14478599P 1999-07-20 1999-07-20
PCT/US2000/006912 WO2000064459A1 (en) 1999-04-27 2000-03-16 Cell therapy for chronic stroke

Publications (1)

Publication Number Publication Date
ATE444758T1 true ATE444758T1 (de) 2009-10-15

Family

ID=26829263

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918005T ATE444758T1 (de) 1999-04-27 2000-03-16 Zelltherapie für chronischen schlaganfall

Country Status (7)

Country Link
EP (1) EP1180036B1 (de)
JP (1) JP2003521474A (de)
AT (1) ATE444758T1 (de)
AU (1) AU780365B2 (de)
CA (1) CA2371017A1 (de)
DE (1) DE60043102D1 (de)
WO (1) WO2000064459A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
WO2007136042A1 (ja) * 2006-05-19 2007-11-29 Aichi Prefecture 脳損傷改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0594669T4 (da) * 1991-07-08 2008-04-21 Neurospheres Holdings Ltd Neurale progenitorceller, som reagerer på vækstfaktorer og kan formeres in vitro
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
WO1998057663A1 (en) * 1997-06-17 1998-12-23 University Technology Corporation Neural transplantation for treating neurological disease

Also Published As

Publication number Publication date
AU3888900A (en) 2000-11-10
AU780365B2 (en) 2005-03-17
EP1180036B1 (de) 2009-10-07
DE60043102D1 (de) 2009-11-19
CA2371017A1 (en) 2000-11-02
EP1180036A1 (de) 2002-02-20
EP1180036A4 (de) 2002-09-25
JP2003521474A (ja) 2003-07-15
WO2000064459A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
Stux et al. Acupuncture: textbook and atlas
Hansen et al. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.
Hsu Acupuncture: a review
Wreje et al. A multicenter randomized controlled trial of injections of sterile water and saline for chronic myofascial pain syndromes
EP1607100A4 (de) Heilmittel mit einem interleukin-6-antagonisten für rückenmarksverletzungen
Lang et al. Prehospital analgesia with acupressure at the Baihui and Hegu points in patients with radial fractures: a prospective, randomized, double-blind trial
BR0315319A (pt) Terapias e procedimentos dentais com toxina botulìnica
CA2387486A1 (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
DE14189577T9 (de) Behandlung von Blasenentzündung mit hochdosiertem Chondroitinsulfat
Yuri et al. Prospects of perineural administration of autologous mesenchymal stem cells of adipose tissue in patients with cerebral infarction
WO2001045715A3 (en) Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
ATE444758T1 (de) Zelltherapie für chronischen schlaganfall
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
EP1949904A3 (de) Zelltherapie für chronische Apoplexie
Mosley et al. Treatment of tension headache in the elderly: A controlled evaluation of relaxation training and relaxation training combined with cognitive-behavior therapy.
EP0279867A3 (de) Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen
ES2710937T3 (es) Métodos para aliviar síntomas de esclerosis múltiple basados en composiciones que contienen apoacuorina
Lesse Combined tranylcypromine-trifluoperazine therapy in the treatment of patients with agitated depressions
JP2003521474A5 (de)
Sodde et al. Occipital Neuralgia and its treatment
Veeraraghavan et al. Anxiety disorders: Psychological assessment and treatment.
Devanand et al. Electroconvulsive therapy-induced hypomania is uncommon
周爽 et al. Effect of acupuncture on neurological defects and daily life ability in patients with acute cerebral hemorrhage
曲雅文 et al. Observation on Clinical Effect of Angelica Injection in Treating Cerebral Infarction Sequela Through Stimulating Nerve Root
Wyler et al. Positive bursts (14-and 6-per second positive spikes) in a patient with a penetrating wound of the brain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties